Gene-Guided diabetes care shows promise in new trial

NCT ID NCT06851962

Ongoing Disease control Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether choosing diabetes medications based on a person's genetic profile helps control blood sugar better than standard treatment. About 500 adults with type 2 diabetes that is not well controlled will be randomly assigned to either gene-guided or standard care. Researchers will compare how many patients reach their blood sugar goal after 24 weeks and track any side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hyperglycemia hypoglycemia type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS, TYPE 2

Contacts and locations

Locations

Hospital Clínico Universitario de Valencia

Valencia, 46010, Spain
Hospital General Universitario de Valencia (HGUV)

Valencia, 46014, Spain
Hospital Universitario Regional de Málaga

Málaga, 29010, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.